Machine Learning Approximations to Predict Epigenetic Age Acceleration in Stroke Patients

Author:

Fernández-Pérez Isabel1ORCID,Jiménez-Balado Joan1,Lazcano Uxue2ORCID,Giralt-Steinhauer Eva1,Rey Álvarez Lucía1,Cuadrado-Godia Elisa13ORCID,Rodríguez-Campello Ana13ORCID,Macias-Gómez Adrià1ORCID,Suárez-Pérez Antoni1,Revert-Barberá Anna1,Estragués-Gázquez Isabel1,Soriano-Tarraga Carolina4,Roquer Jaume13,Ois Angel13ORCID,Jiménez-Conde Jordi13ORCID

Affiliation:

1. Neurovascular Research Group, Department of Neurology, IMIM-Hospital del Mar (Institut Hospital del Mar d’Investigacions Mèdiques), 08003 Barcelona, Spain

2. Unidad de Investigación AP-OSIs Guipúzcoa, 20014 Donostia, Spain

3. Medicine Department, DCEXS-Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain

4. Department of Psychiatry, NeuroGenomics and Informatics, Washington University School of Medicine, St. Louis, MO 63110, USA

Abstract

Age acceleration (Age-A) is a useful tool that is able to predict a broad range of health outcomes. It is necessary to determine DNA methylation levels to estimate it, and it is known that Age-A is influenced by environmental, lifestyle, and vascular risk factors (VRF). The aim of this study is to estimate the contribution of these easily measurable factors to Age-A in patients with cerebrovascular disease (CVD), using different machine learning (ML) approximations, and try to find a more accessible model able to predict Age-A. We studied a CVD cohort of 952 patients with information about VRF, lifestyle habits, and target organ damage. We estimated Age-A using Hannum’s epigenetic clock, and trained six different models to predict Age-A: a conventional linear regression model, four ML models (elastic net regression (EN), K-Nearest neighbors, random forest, and support vector machine models), and one deep learning approximation (multilayer perceptron (MLP) model). The best-performing models were EN and MLP; although, the predictive capability was modest (R2 0.358 and 0.378, respectively). In conclusion, our results support the influence of these factors on Age-A; although, they were not enough to explain most of its variability.

Funder

Instituto de Salud Carlos III

Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III

“Registro BASICMAR” Funding for Research in Health

Fondos de Investigación Sanitaria ISC III

Recercaixa’13

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference64 articles.

1. Ageing as a Risk Factor for Disease;Niccoli;Curr. Biol.,2012

2. Ageing Populations: The Challenges Ahead;Christensen;Lancet,2009

3. Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers;Diebel;Curr. Oncol. Rep.,2021

4. Biomarkers of Aging;Baker;Exp. Gerontol.,1988

5. Epigenetic Modifications and Human Disease;Portela;Nat. Biotechnol.,2010

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Integration of epigenetic regulatory mechanisms in heart failure;Basic Research in Cardiology;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3